These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1114518)

  • 21. A critical evaluation of HL-A phenotype and genotype frequencies in a large German population determined by platelet complement fixation and lymphocytotoxicity.
    Mueller-Eckhardt C; Heinrich D; Mersch-Baumert K; Czitrom A; Walker P
    Humangenetik; 1974; 24(4):319-24. PubMed ID: 4442875
    [No Abstract]   [Full Text] [Related]  

  • 22. Another example of anti-HL-A8 reacting by platelet complement fixation microtechnique.
    de Mouzon A; Ohayon E; Pris J; Julien F
    Vox Sang; 1976; 31(1):58-60. PubMed ID: 936565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti HL-A transfusion immunization after extracorporeal circulation].
    Colombani J; Colombani M; Dastot H; Terrier E; Baillet M; Jaulmes B
    Nouv Rev Fr Hematol; 1972; 12(2):201-16. PubMed ID: 4264614
    [No Abstract]   [Full Text] [Related]  

  • 24. HL-A antigens and susceptibility to diseases. A study of patients with acute lymphoblastic leukaemia, Hodgkin's disease, and childhood asthma.
    Thorsby E; Engeset A; Lie SO
    Tissue Antigens; 1971; 1(3):147-52. PubMed ID: 5292820
    [No Abstract]   [Full Text] [Related]  

  • 25. HL-A antigens of patients with sarcoidosis.
    Kueppers F; Mueller-Eckhardt C; Heinrich D; Schwab B; Brackertz D
    Tissue Antigens; 1974; 4(1):56-8. PubMed ID: 4837314
    [No Abstract]   [Full Text] [Related]  

  • 26. Typing for the MLC determinants and its possible impact on Europdonor.
    van Rood JJ; van Leeuwen A; van den Tweel JG; Blussé van Oud Alblas A; Keuning JJ; Eernisse JG
    Transplant Proc; 1974 Dec; 6(4):411-5. PubMed ID: 4140594
    [No Abstract]   [Full Text] [Related]  

  • 27. Some observations on the immune response to HL-A antigens in pregnancy.
    Tovey GH; Darke CC
    Haematologia (Budap); 1973; 7(2):171-6. PubMed ID: 4789723
    [No Abstract]   [Full Text] [Related]  

  • 28. A non-complement-fixing antibody, segregating with HL-A3, detected on lymphocytes by immunofluorescence.
    Lepage V; Dausset J
    Transplantation; 1975 Dec; 20(6):517-9. PubMed ID: 1108319
    [No Abstract]   [Full Text] [Related]  

  • 29. HL-A and lymphoid tumors.
    Dick FR; Fortuny I; Theologides A; Greally J; Wood N; Yunis EJ
    Cancer Res; 1972 Dec; 32(12):2608-11. PubMed ID: 4509228
    [No Abstract]   [Full Text] [Related]  

  • 30. Burkitt's lymphoma and HL-A antigens.
    Dick HM; Steel CM; Levin AG; Henderson N
    Tissue Antigens; 1975 Feb; 5(1):52-8. PubMed ID: 1138442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of HL-A specificities shown by platelet complement-fixation.
    Mittal KK; Mickey MR; Terasaki PI
    Tissue Antigens; 1971; 1(6):279-85. PubMed ID: 4116729
    [No Abstract]   [Full Text] [Related]  

  • 32. Disease predisposition, immune responsiveness and the fine structure of the HL-A supergene. A need for a reappraisal.
    Rood JJ; Hooff JP; Keuning JJ
    Transplant Rev; 1975; 22():75-104. PubMed ID: 46646
    [No Abstract]   [Full Text] [Related]  

  • 33. Human lymphocyte-dependent antibody mediated cytotoxicity and direct lymphocyte cytotoxicity against non-HL-A antigens.
    Yust I; Wunderlich J; Mann DL; Rogentine GN; Leventhal B; Yankee R; Graw R
    Nature; 1974 May; 249(454):263-5. PubMed ID: 4275318
    [No Abstract]   [Full Text] [Related]  

  • 34. The histocompatibility complex of rhesus monkeys. I. Serology and genetics of the RhL-A system.
    Balner H; Gabb BW; Toth EK; Dersjant H; van Vreeswijk W
    Tissue Antigens; 1973; 3(4):257-72. PubMed ID: 4203444
    [No Abstract]   [Full Text] [Related]  

  • 35. [HL-A and disease].
    Feltkamp TE
    Ned Tijdschr Geneeskd; 1977 Sep; 121(36):1399-401. PubMed ID: 302424
    [No Abstract]   [Full Text] [Related]  

  • 36. HL-A antigens in Hodgkin's disease; histopathologic and clinical correlations.
    Graff KS; Simon RM; Yankee RA; DEVita VT; Rogentine GN
    J Natl Cancer Inst; 1974 Apr; 52(4):1087-90. PubMed ID: 4826579
    [No Abstract]   [Full Text] [Related]  

  • 37. Selection of unrelated compatible platelet donors by lymphocyte HL-A matching.
    Yankee RA; Graff KS; Dowling R; Henderson ES
    N Engl J Med; 1973 Apr; 288(15):760-4. PubMed ID: 4688715
    [No Abstract]   [Full Text] [Related]  

  • 38. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 39. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
    Gaines JD; Gilmer MA; Remington JS
    Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of HL-A antigens in patients with Hodgkin's disease and their families.
    Forbes JF; Morris PJ
    J Clin Invest; 1972 May; 51(5):1156-63. PubMed ID: 5020429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.